ALKS
USDAlkermes plc Ordinary Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$30.000
Kõrge
$30.630
Madal
$29.770
Maht
0.42M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
5.0B
Tööstusharu
Drug Manufacturers - Specialty & Generic
Riik
Ireland
Kauplemisstatistika
Keskmine maht
2.00M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Wells Fargo Maintains Overweight on Alkermes, Lowers Price Target to $42
Wells Fargo analyst Benjamin Burnett maintains Alkermes with a Overweight and lowers the price target from $44 to $42.
Needham Maintains Buy on Alkermes, Raises Price Target to $44
Needham analyst Ami Fadia maintains Alkermes with a Buy and raises the price target from $43 to $44.
Alkermes plc Reports Third Quarter 2025 Financial Results
Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving ...
Mizuho Maintains Outperform on Alkermes, Raises Price Target to $45
Mizuho analyst Uy Ear maintains Alkermes with a Outperform and raises the price target from $40 to $45.
Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $45
Piper Sandler analyst David Amsellem reiterates Alkermes with a Overweight and raises the price target from $38 to $45.
RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $47
RBC Capital analyst Leonid Timashev maintains Alkermes with a Outperform and raises the price target from $45 to $47.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.